New study by Professor Yoon-Kyoung Cho validates urine-based biomarkers for early detection of cancer.
A team of researchers, led by Professor Yoon-Kyoung Cho of Life Science at UNIST has recently developed a new technique that effectively identifies cancer-causing substances in the urine or blood.
In the study, Professor Yoon-Kyoung Cho of Life Science, a group leader at IBS Research Center for Soft and Living Matter (CSLM) presented an integrated centrifugal microfluidic
platform (Exodisc), a device that isolates extracellular vesicles (EVs) from urine.
The results of the study has been published in the February issue of ACS Nano journal. The research team expects that this may be potentially useful in clinical settings to test urinary EV-based biomarkers for cancer diagnostics.
Despite the increasing clinical importance of EVs as potential biomarkers in the diagnosis and prognosis of various diseases, current methods of EV isolation and analysis suffer from complicated procedures with long processing times. For instance, even ultracentrifugation (UC), the most commonly used method for EV isolation, requires time-consuming steps involving centrifugation and acquisition of large sample volumes, and the results suffer from low yield and purity.
To overcome these limitations, Professor Cho presented a new lab-on-a-disc platform for rapid, size-selective, and efficient isolation and analysis of nanoscale EVs from raw biological samples, such as cell-culture supernatant (CCS) or cancer-patient urine.
“The Exodisc is compoased of two independent filteration units (20nm and 600nm in size) within a disk-shaped chip to enable the processing of two different samples simulateously,” says Hyun-Kyung Woo (Combined M.S./Ph.D. student of Natural Science), the first author of the study. “Upon spinning the disc, the urine sample is transferred through two integrated nanofilters, allowing for the enrichment of unirary EVs within the size range of 20 to 600 nm.”
The hole sizes in nanoporous filters mounted on the Exodisc were set arbitrarily to seperate the nanoscale vesicles effectively from germs or unnecessary proteins. The direct detection of urinary EVs from patients with bladder cancer was validated successfully, using on-disc enzyme-linked immunosorbent assay (ELISA).
“Using Exodisc, it is possible to isolate EVs from raw samples within 30 minutes,” says Professor Cho. “The process of passing the filter through centrifugal force is automatically carried out, effectively recovering the enriched EVs.”
In the study, the research team examined clinical samples by analyzing urinary EVs from bladder cancer patients, using a tabletop-sized centrifugal microfluidic system. As a result, fully automated enrichment of unirary EVs in the size range of 20?600 nm was achieved within 30 min Quantitative tests.
“On-disc ELISA using urinary EVs isolated from bladder cancer patients showed high levels of CD9 and CD81 expression, suggesting that this method may be potentially useful in clinical settings to test urinary EV-based biomarkers for cancer diagnostics,” says Vijaya Sunkara of Life Sciences, the co-first author.
“We are currently conducting further studies to determine various diseases, including cancer by analyzing the collected nanoparticles,” says Professor Cho. “We hope this device can contribute significantly to the advancement of studies related to tumor biology and acceleration of the practical use of EV-based liquid biopsies for personalized medicine in clinical settings,” says Professor Cho.
Receive an email update when we add a new CANCER DIAGNOSTICS article.
The Latest on: Cancer diagnostics
via Google News
The Latest on: Cancer diagnostics
- EastEnders spoilers: Jean Slater goes missing after struggling to cope with cancer diagnosis on February 18, 2019 at 11:32 pm
She packs a bag and leaves Walford after her family discover the truth about her health As the week kicks off, Jean – played by Gillian Wright in the BBC soap - is troubled and ends up grilling Sonia ... […]
- TV personality Chiemi Hori announces advanced-stage cancer diagnosis and vows not to 'lose this battle' on February 18, 2019 at 10:51 pm
TV personality and former pop idol Chiemi Hori, 52, said she has been diagnosed with stage 4 tongue cancer — the most advanced stage of the disease — in an official blog post published Tuesday. Hori a... […]
- Broad Institute targets blood-draw diagnostics on February 18, 2019 at 9:15 pm
With pledges of $25 million, the nonprofit Broad Institute of MIT and Harvard plans to announce Tuesday that it’s creating a new center to develop a diagnostic test to pinpoint how well cancer patient... […]
- MDxHealth Announces Presentation of Positive Data for SelectMDx and ConfirmMDx in Prostate Cancer Diagnosis on February 18, 2019 at 7:57 pm
San Francisco, CA USA (UroToday.com) --MDxHealth SA announced that positive data and observations from multiple studies and patient registries demonstrating the value of SelectMDx and ConfirmMDx for P... […]
- The global liver cancer diagnostics market size is expected to reach USD 15.4 billion by 2025 on February 18, 2019 at 4:03 pm
Liver Cancer Diagnostic Market Size, Share & Trends Analysis Report By Screening Type (Biopsy, Endoscopy, Laboratory Tests, Imaging), By Region (North America, APAC, Europe), And Segment Forecasts, 20... […]
- Mom gets new tongue made from arm after cancer diagnosis on February 18, 2019 at 7:42 am
A 58-year-old woman who was reportedly faced with either surgically removing part of her tongue or succumbing to cancer within months has had a new one fashioned out of a vein and pieces of her arm. J... […]
- Cancer Diagnostics Startup Paige.AI Names Med-Tech Executive Leo Grady CEO on February 18, 2019 at 3:14 am
Paige.AI, launched last year with $25 million in venture capital and a licensing deal with Memorial Sloan Kettering Cancer Center, has hired a chief executive to lead the development of a product aime... […]
- Cervical Cancer Diagnostic Testing Market Size, Trends Analysis, Top Manufacturers, Shares, Growth Opportunities, Statistics & Forecast to 2023 on February 18, 2019 at 1:03 am
Feb 18, 2019 (Heraldkeeper via COMTEX) -- MarketStudyReport.com add New Report Global Cervical Cancer Diagnostic Testing Market to its research database. The report focuses on global major leading pla... […]
- Man's bladder rebuilt after cancer diagnosis on February 16, 2019 at 5:53 pm
(KSL) - Advances in cancer treatment have led to life-saving options in even the worst cases. For a Utah man, a critical organ ravaged by cancer was totally re-engineered to save him. Tom Ramsey loves ... […]
via Bing News